Masaka, Uganda | THE INDEPENDENT | Researchers are studying the effectiveness of a daily Pre-Exposure Prophylaxis (PrEP) drug Descovy in their HIV vaccine study that was launched recently in Masaka district. Dr Eugene Ruzagira, a member of the team of researchers told a news conference organized by the Health Journalists Network …
Read More »157 Ugandans enrolled in largest HIV vaccine trial in Africa
Kampala, Uganda | THE INDEPENDENT | A total of 157 volunteers have so far enrolled in a study happening in Masaka, one of the sites that have been selected to assess effectiveness of a vaccine against HIV in Africa. The study dubbed PrEPVACC is also happening in Mbeya and Dar-es- Salaam …
Read More »